Business Wire

CGTN

23.3.2021 20:56:07 CET | Business Wire | Press release

Share
CGTN:Why Did Xi Jinping Make Fujian His First Stop After Five-year Plan Approval?

As China's latest medium and long-term economic and social development plan was just approved at the country's top legislature, President Xi Jinping has left Beijing for his first inspection trip to east China's Fujian Province after the Two Sessions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210323006017/en/

Xi's visits to an ecological tea garden and the Wuyishan National Park during the inspection show the importance he attaches to green, ecological development, which was also stressed in China's road map for development for the next five years and beyond.

Wuyi Mountain and ecological protection

Standing in the suburbs of Wuyishan City, Mount Wuyi entered UNESCO's list of World Heritage Sites in 1999. It covers an area of over 630 square kilometers and numerous types of tea are produced there.

Visiting mountains is usually arranged in Xi's inspection tours as construction of ecological civilization has always been stressed by the president.

In April 2020, Xi's first stop was also to visit the mountains. He went directly to the Qinling Mountains during his inspection in northwest China's Shaanxi Province to learn about ecological protection, urging officials to be guardians of ecological environment.

In August 2019, he went to northwest China's Gansu Province and visited the Qilian Mountains, underlining ecological protection as a national strategy.

On Monday, during his visit to the Wuyishan National Park, he encountered a group of tourists. "You can enjoy the mountain scenery in Wuyishan and enjoy the seascape in Xiamen City," he told the group.

Xi also visited the park's intelligent management center, where all the weather monitoring and services for biological resources within the park are conducted.

During the just-concluded Two Sessions, he said top-level design and comprehensive measures are needed to protect the ecosystems in mountains, rivers, forests, farmlands, lakes, grasslands and deserts.

Tea industry and rural vitalization

"In the past, the tea industry was a pillar in your fight against poverty, and it should become a pillar industry of rural vitalization in the future," Xi said on Monday at the tea garden.

He called for efforts to better cultivate a vibrant tea industry that takes advantage of Mount Wuyi's long history of tea culture, suitable climate, rich tea resources and the support of science and technology.

Shaking off poverty is not the finish line but the starting line of a new life and new endeavor, Xi said in February after announcing that China has secured a "complete victory" in its fight against poverty, urging efforts to effectively integrate the consolidation of poverty alleviation achievements and rural vitalization.

China detailed plans to fully promote the strategy of rural vitalization in the Chinese leadership's proposals for formulating the 14th Five-Year Plan (2021-2025) for National Economic and Social Development and the Long-Range Objectives Through the Year 2035.

Under this development blueprint, the country will push the development of industries with distinctive rural characteristics, cultivate new industries and modes of business, and encourage entrepreneurship and innovation in rural areas.

During his stop at the tea garden, Xi was pleased when hearing that the quality of tea was greatly improved through ecological planting in recent years, under the guidance of the team of technology commissioners.

Agricultural talents, also called "technological commissioners," was an idea introduced by Xi, the then governor to Fujian Province in a 2002 article, which called for bonding officials and farmers.

The president has stressed the role of science and technology in poverty alleviation and rural revitalization many times, calling for efforts to promote science and technological innovation in agriculture to support all-around rural revitalization.

During the inspection, Xi also visited a park dedicated to Zhu Xi, a renowned Chinese philosopher in the 12th century, in Nanping City on Monday afternoon, learning about local efforts to pass on traditional culture.

https://news.cgtn.com/news/2021-03-23/Xi-Jinping-makes-Fujian-his-first-stop-after-Five-Year-Plan-approval-YRH8REcXW8/index.html

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye